001     136114
005     20250325111223.0
024 7 _ |a 10.1002/psc.1227
|2 doi
024 7 _ |a pmid:20862726
|2 pmid
024 7 _ |a 1075-2617
|2 ISSN
024 7 _ |a 1099-1387
|2 ISSN
037 _ _ |a DZNE-2020-02436
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Chu, Nam Ky
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Protein immobilization on liposomes and lipid-coated nanoparticles by protein trans-splicing.
260 _ _ |a New York, NY [u.a.]
|c 2010
|b Wiley
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2010-09-16
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2010-10-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1742897502_32038
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a A plethora of methods exist to link proteins to surfaces in order to generate functionalized materials. However, general tools that lead to functional immobilization of recombinantly expressed proteins on membranes such as liposomes or lipid-coated nanoparticles are rare. Here we present an approach that takes advantage of a double-palmitoylated peptide that mediates stable membrane anchoring in combination with protein trans-splicing for efficient immobilization of recombinant proteins fused to split intein segments. Two different DnaE split inteins from Synechocystis and Nostoc punctiforme are tested and compared to immobilization via direct native chemical ligation using a protein thioester. Protein trans-splicing proceeds at low protein concentrations and leads to functionalized vesicles and membrane-coated silica nanoparticles.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 1
542 _ _ |i 2015-09-01
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Immobilized Proteins
|2 NLM Chemicals
650 _ 7 |a Lipids
|2 NLM Chemicals
650 _ 7 |a Liposomes
|2 NLM Chemicals
650 _ 7 |a Recombinant Fusion Proteins
|2 NLM Chemicals
650 _ 2 |a Immobilized Proteins: chemistry
|2 MeSH
650 _ 2 |a Immobilized Proteins: metabolism
|2 MeSH
650 _ 2 |a Inteins: genetics
|2 MeSH
650 _ 2 |a Lipids: chemistry
|2 MeSH
650 _ 2 |a Liposomes: metabolism
|2 MeSH
650 _ 2 |a Models, Molecular
|2 MeSH
650 _ 2 |a Nanoparticles: chemistry
|2 MeSH
650 _ 2 |a Nostoc: genetics
|2 MeSH
650 _ 2 |a Protein Splicing
|2 MeSH
650 _ 2 |a Recombinant Fusion Proteins: chemistry
|2 MeSH
650 _ 2 |a Recombinant Fusion Proteins: genetics
|2 MeSH
650 _ 2 |a Recombinant Fusion Proteins: metabolism
|2 MeSH
650 _ 2 |a Synechocystis: genetics
|2 MeSH
650 _ 2 |a Trans-Splicing
|2 MeSH
700 1 _ |a Olschewski, Diana
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Seidel, Ralf
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Winklhofer, Konstanze F
|0 P:(DE-2719)9000369
|b 3
700 1 _ |a Tatzelt, Jörg
|0 P:(DE-2719)9000396
|b 4
|u dzne
700 1 _ |a Engelhard, Martin
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Becker, Christian F W
|0 P:(DE-HGF)0
|b 6
|e Corresponding author
770 _ _ |a Probing Protein Function through Chemistry
773 1 8 |a 10.1002/psc.1227
|b : Wiley, 2010-09-16
|n 10
|p 582-588
|3 journal-article
|2 Crossref
|t Journal of Peptide Science
|v 16
|y 2010
|x 1075-2617
773 _ _ |a 10.1002/psc.1227
|g Vol. 16, no. 10, p. 582 - 588
|0 PERI:(DE-600)1491819-5
|n 10
|q 16:10<582 - 588
|p 582-588
|t Journal of peptide science
|v 16
|y 2010
|x 1075-2617
856 4 _ |u https://pub.dzne.de/record/136114/files/DZNE-2020-02436_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/136114/files/DZNE-2020-02436_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:136114
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000369
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9000396
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 1
914 1 _ |y 2010
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J PEPT SCI : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)6000016
|k München common
|l München common
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)6000016
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1105654
|2 Crossref
|o 10.1126/science.1105654
999 C 5 |9 -- missing cx lookup --
|a 10.1002/(SICI)1521-3765(19990401)5:4<1239::AID-CHEM1239>3.0.CO;2-N
|2 Crossref
|o 10.1002/(SICI)1521-3765(19990401)5:4<1239::AID-CHEM1239>3.0.CO;2-N
999 C 5 |9 -- missing cx lookup --
|a 10.1002/anie.200600855
|2 Crossref
|o 10.1002/anie.200600855
999 C 5 |9 -- missing cx lookup --
|a 10.1021/ja052407f
|2 Crossref
|o 10.1021/ja052407f
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1742-4658.2006.05152.x
|2 Crossref
|o 10.1111/j.1742-4658.2006.05152.x
999 C 5 |9 -- missing cx lookup --
|a 10.1021/bc0602782
|2 Crossref
|o 10.1021/bc0602782
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.7973629
|2 Crossref
|o 10.1126/science.7973629
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrd1632
|2 Crossref
|o 10.1038/nrd1632
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nmeth886
|2 Crossref
|o 10.1038/nmeth886
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.bioeng.2005.07.004
|2 Crossref
|o 10.1016/j.bioeng.2005.07.004
999 C 5 |9 -- missing cx lookup --
|a 10.1021/ja0456611
|2 Crossref
|o 10.1021/ja0456611
999 C 5 |9 -- missing cx lookup --
|a 10.1002/anie.200503475
|2 Crossref
|o 10.1002/anie.200503475
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1399-3011.1992.tb00291.x
|2 Crossref
|o 10.1111/j.1399-3011.1992.tb00291.x
999 C 5 |y 1989
|2 Crossref
|t Solid Phase Peptide Synthesis: A Practical Approach.
|o Atherton Solid Phase Peptide Synthesis: A Practical Approach. 1989
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.275.13.9091
|2 Crossref
|o 10.1074/jbc.275.13.9091
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.febslet.2006.02.045
|2 Crossref
|o 10.1016/j.febslet.2006.02.045
999 C 5 |9 -- missing cx lookup --
|a 10.1021/ja9909879
|2 Crossref
|o 10.1021/ja9909879
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M313212200
|2 Crossref
|o 10.1074/jbc.M313212200
999 C 5 |9 -- missing cx lookup --
|a 10.1021/bi0494065
|2 Crossref
|o 10.1021/bi0494065
999 C 5 |9 -- missing cx lookup --
|a 10.1021/ja034736i
|2 Crossref
|o 10.1021/ja034736i
999 C 5 |9 -- missing cx lookup --
|a 10.1021/ja042287w
|2 Crossref
|o 10.1021/ja042287w
999 C 5 |9 -- missing cx lookup --
|a 10.1021/bi001786g
|2 Crossref
|o 10.1021/bi001786g
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.febslet.2009.02.003
|2 Crossref
|o 10.1016/j.febslet.2009.02.003
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0005185
|2 Crossref
|o 10.1371/journal.pone.0005185
999 C 5 |9 -- missing cx lookup --
|a 10.1002/anie.200600570
|2 Crossref
|o 10.1002/anie.200600570
999 C 5 |9 -- missing cx lookup --
|a 10.1002/bit.21912
|2 Crossref
|o 10.1002/bit.21912


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21